Madhav Vasanthavada
CIK: 0002106295
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABEONA THERAPEUTICS INC.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 29, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct4.9K shares at avg. $5.16$25K - Jul 9, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct12.6K shares at avg. $6.96$88K - Jun 16, 2026ABEO
ABEONA THERAPEUTICS INC.
Other(J)Direct222 shares at avg. $5.67$1K - Jun 9, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct5.5K shares at avg. $5.30$29K - Jun 8, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct4.2K shares at avg. $5.43$23K - May 11, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct5.5K shares at avg. $5.96$33K - Jan 22, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct12.6K shares at avg. $5.29$67K - Jan 20, 2026ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct76.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 4,902 | $5.16 | $25,273 | Direct |
| Jul 9, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 12,606 | $6.96 | $87,784 | Direct |
| Jun 16, 2026 | ABEO ABEONA THERAPEUTICS INC. | Other(J) | 222 | $5.67 | $1,259 | Direct |
| Jun 9, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 5,450 | $5.30 | $28,908 | Direct |
| Jun 8, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 4,170 | $5.43 | $22,641 | Direct |
| May 11, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 5,548 | $5.96 | $33,073 | Direct |
| Jan 22, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 12,610 | $5.29 | $66,658 | Direct |
| Jan 20, 2026 | ABEO ABEONA THERAPEUTICS INC. | Award(A) | 76,621 | - | $0 | Direct |
1-8 of 8 transactions
About Vasanthavada Madhav
Vasanthavada Madhav (SEC CIK 0002106295) files insider reports with the SEC as Chief Commercial Officer of ABEONA THERAPEUTICS INC. (ABEO).
Signal8 holds 7 ownership filings by Vasanthavada Madhav (1 Form 3, 6 Form 4), filed between Jan 26, 2026 and Sep 29, 2026. Those filings report 8 transactions, from Jan 20, 2026 to Sep 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vasanthavada Madhav's filings is in CLEVELAND, OH.
Recent filings by Vasanthavada Madhav
- Sep 29, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jul 9, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jun 16, 2026: Other transaction of ABEO shares (Form 4, code J).
- Jun 9, 2026: Open-market sale of ABEO shares (Form 4, code S).
- Jun 8, 2026: Open-market sale of ABEO shares (Form 4, code S).
Other insiders filing for ABEONA THERAPEUTICS INC. (ABEO)
- Seshadri Vishwas, Chief Executive Officer
- Vazzano Joseph Walter, Chief Financial Officer
- O'Malley Brendan M., SVP, Chief Legal Officer
- Alvino Mark, Director
- Alland Leila, Director
- Silverstein Christine Berni, Director